Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Trypsin treatment unlocks barrier for zoonotic bat coronaviruses infection.

Menachery VD, Dinnon KH 3rd, Yount BL Jr, McAnarney ET, Gralinski LE, Hale A, Graham RL, Scobey T, Anthony SJ, Wang L, Graham B, Randell SH, Lipkin WI, Baric RS.

J Virol. 2019 Dec 4. pii: JVI.01774-19. doi: 10.1128/JVI.01774-19. [Epub ahead of print]

PMID:
31801868
2.

Immune predictors of mortality following RNA virus infection.

Graham JB, Swarts JL, Menachery VD, Gralinski LE, Schäfer A, Plante KS, Morrison CR, Voss KM, Green R, Choonoo G, Jeng S, Miller DR, Mooney MA, McWeeney SK, Ferris MT, Pardo-Manuel de Villena F, Gale M, Heise MT, Baric RS, Lund JM.

J Infect Dis. 2019 Oct 17. pii: jiz531. doi: 10.1093/infdis/jiz531. [Epub ahead of print]

PMID:
31621854
3.

Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity.

Johnson BA, Hage A, Kalveram B, Mears M, Plante JA, Rodriguez SE, Ding Z, Luo X, Bente D, Bradrick SS, Freiberg AN, Popov V, Rajsbaum R, Rossi S, Russell WK, Menachery VD.

J Virol. 2019 Oct 29;93(22). pii: e01282-19. doi: 10.1128/JVI.01282-19. Print 2019 Nov 15.

PMID:
31462558
4.

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity.

Dinnon Iii KH, Gallichotte EN, Fritch EJ, Menachery VD, Baric RS.

PLoS Negl Trop Dis. 2019 Mar 7;13(3):e0007212. doi: 10.1371/journal.pntd.0007212. eCollection 2019 Mar.

5.

Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.

Schindewolf C, Menachery VD.

Viruses. 2019 Jan 17;11(1). pii: E74. doi: 10.3390/v11010074. Review.

6.

SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus).

van Doremalen N, Schäfer A, Menachery VD, Letko M, Bushmaker T, Fischer RJ, Figueroa DM, Hanley PW, Saturday G, Baric RS, Munster VJ.

Viruses. 2018 Dec 19;10(12). pii: E727. doi: 10.3390/v10120727.

7.

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.

Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS.

MBio. 2018 Oct 9;9(5). pii: e01753-18. doi: 10.1128/mBio.01753-18.

8.

Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines.

Menachery VD, Gralinski LE, Mitchell HD, Dinnon KH 3rd, Leist SR, Yount BL Jr, McAnarney ET, Graham RL, Waters KM, Baric RS.

J Virol. 2018 Aug 16;92(17). pii: e00710-18. doi: 10.1128/JVI.00710-18. Print 2018 Sep 1.

9.

CC002/Unc females are mouse models of exercise-induced paradoxical fat response.

McMullan RC, Ferris MT, Bell TA, Menachery VD, Baric RS, Hua K, Pomp D, Smith-Ryan AE, de Villena FP.

Physiol Rep. 2018 Jun;6(12):e13716. doi: 10.14814/phy2.13716.

10.

Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.

Agnihothram S, Menachery VD, Yount BL Jr.,, Lindesmith LC, Scobey T, Whitmore A, Schäfer A, Heise MT, Baric RS.

J Virol. 2018 May 14;92(11). pii: e00027-18. doi: 10.1128/JVI.00027-18. Print 2018 Jun 1.

11.

MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape.

Menachery VD, Schäfer A, Burnum-Johnson KE, Mitchell HD, Eisfeld AJ, Walters KB, Nicora CD, Purvine SO, Casey CP, Monroe ME, Weitz KK, Stratton KG, Webb-Robertson BM, Gralinski LE, Metz TO, Smith RD, Waters KM, Sims AC, Kawaoka Y, Baric RS.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E1012-E1021. doi: 10.1073/pnas.1706928115. Epub 2018 Jan 16.

12.

Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses.

Johnson BA, Graham RL, Menachery VD.

Virology. 2018 Apr;517:30-37. doi: 10.1016/j.virol.2017.12.009. Epub 2017 Dec 24. Review.

13.

Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis.

Menachery VD, Gralinski LE, Mitchell HD, Dinnon KH 3rd, Leist SR, Yount BL Jr, Graham RL, McAnarney ET, Stratton KG, Cockrell AS, Debbink K, Sims AC, Waters KM, Baric RS.

mSphere. 2017 Nov 15;2(6). pii: e00346-17. doi: 10.1128/mSphere.00346-17. eCollection 2017 Nov-Dec.

14.

CD-loop Extension in Zika Virus Envelope Protein Key for Stability and Pathogenesis.

Gallichotte EN, Dinnon KH 3rd, Lim XN, Ng TS, Lim EXY, Menachery VD, Lok SM, Baric RS.

J Infect Dis. 2017 Dec 5;216(10):1196-1204. doi: 10.1093/infdis/jix473.

15.

MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis.

Menachery VD, Mitchell HD, Cockrell AS, Gralinski LE, Yount BL Jr, Graham RL, McAnarney ET, Douglas MG, Scobey T, Beall A, Dinnon K 3rd, Kocher JF, Hale AE, Stratton KG, Waters KM, Baric RS.

MBio. 2017 Aug 22;8(4). pii: e00665-17. doi: 10.1128/mBio.00665-17.

16.

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric RS.

Sci Transl Med. 2017 Jun 28;9(396). pii: eaal3653. doi: 10.1126/scitranslmed.aal3653.

17.

Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice.

Gralinski LE, Menachery VD, Morgan AP, Totura AL, Beall A, Kocher J, Plante J, Harrison-Shostak DC, Schäfer A, Pardo-Manuel de Villena F, Ferris MT, Baric RS.

G3 (Bethesda). 2017 Jun 7;7(6):1653-1663. doi: 10.1534/g3.117.041434.

18.

Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus.

Anthony SJ, Gilardi K, Menachery VD, Goldstein T, Ssebide B, Mbabazi R, Navarrete-Macias I, Liang E, Wells H, Hicks A, Petrosov A, Byarugaba DK, Debbink K, Dinnon KH, Scobey T, Randell SH, Yount BL, Cranfield M, Johnson CK, Baric RS, Lipkin WI, Mazet JA.

MBio. 2017 Apr 4;8(2). pii: e00373-17. doi: 10.1128/mBio.00373-17.

19.

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone.

Gallichotte EN, Menachery VD, Yount BL Jr, Widman DG, Dinnon KH 3rd, Hartman S, de Silva AM, Baric RS.

mSphere. 2017 Feb 22;2(1). pii: e00380-16. doi: 10.1128/mSphere.00380-16. eCollection 2017 Jan-Feb.

20.

Jumping species-a mechanism for coronavirus persistence and survival.

Menachery VD, Graham RL, Baric RS.

Curr Opin Virol. 2017 Apr;23:1-7. doi: 10.1016/j.coviro.2017.01.002. Epub 2017 Mar 31. Review.

21.

Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.

Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS.

Nat Med. 2016 Apr;22(4):446. doi: 10.1038/nm0416-446d. No abstract available.

PMID:
27050591
22.

SARS-like WIV1-CoV poised for human emergence.

Menachery VD, Yount BL Jr, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, Swanstrom J, Sheahan TP, Pickles RJ, Corti D, Randell SH, Lanzavecchia A, Marasco WA, Baric RS.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53. doi: 10.1073/pnas.1517719113. Epub 2016 Mar 14.

23.

MERS Vaccine Candidate Offers Promise, but Questions Remain.

Menachery VD.

EBioMedicine. 2015 Sep 25;2(10):1292-3. doi: 10.1016/j.ebiom.2015.09.037. eCollection 2015 Oct. No abstract available.

24.

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.

Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS.

Nat Med. 2015 Dec;21(12):1508-13. doi: 10.1038/nm.3985. Epub 2015 Nov 9. Erratum in: Nat Med. 2016 Apr;22(4):446.

25.

Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross.

Gralinski LE, Ferris MT, Aylor DL, Whitmore AC, Green R, Frieman MB, Deming D, Menachery VD, Miller DR, Buus RJ, Bell TA, Churchill GA, Threadgill DW, Katze MG, McMillan L, Valdar W, Heise MT, Pardo-Manuel de Villena F, Baric RS.

PLoS Genet. 2015 Oct 9;11(10):e1005504. doi: 10.1371/journal.pgen.1005504. eCollection 2015 Oct.

26.

New Metrics for Evaluating Viral Respiratory Pathogenesis.

Menachery VD, Gralinski LE, Baric RS, Ferris MT.

PLoS One. 2015 Jun 26;10(6):e0131451. doi: 10.1371/journal.pone.0131451. eCollection 2015.

27.

Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates.

Selinger C, Tisoncik-Go J, Menachery VD, Agnihothram S, Law GL, Chang J, Kelly SM, Sova P, Baric RS, Katze MG.

BMC Genomics. 2014 Dec 22;15:1161. doi: 10.1186/1471-2164-15-1161.

28.

Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments.

Menachery VD, Debbink K, Baric RS.

Virus Res. 2014 Dec 19;194:191-9. doi: 10.1016/j.virusres.2014.09.009. Epub 2014 Sep 30. Review.

29.

Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses.

Menachery VD, Eisfeld AJ, Schäfer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams CM, Weiss J, Matzke MM, Webb-Robertson BJ, Schepmoes AA, Shukla AK, Metz TO, Smith RD, Waters KM, Katze MG, Kawaoka Y, Baric RS.

MBio. 2014 May 20;5(3):e01174-14. doi: 10.1128/mBio.01174-14.

30.

A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.

Agnihothram S, Yount BL Jr, Donaldson EF, Huynh J, Menachery VD, Gralinski LE, Graham RL, Becker MM, Tomar S, Scobey TD, Osswald HL, Whitmore A, Gopal R, Ghosh AK, Mesecar A, Zambon M, Heise M, Denison MR, Baric RS.

MBio. 2014 Mar 25;5(2):e00047-14. doi: 10.1128/mBio.00047-14.

31.

Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.

Menachery VD, Yount BL Jr, Josset L, Gralinski LE, Scobey T, Agnihothram S, Katze MG, Baric RS.

J Virol. 2014 Apr;88(8):4251-64. doi: 10.1128/JVI.03571-13. Epub 2014 Jan 29.

32.

Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.

Agnihothram S, Gopal R, Yount BL Jr, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS.

J Infect Dis. 2014 Apr 1;209(7):995-1006. doi: 10.1093/infdis/jit609. Epub 2013 Nov 18.

33.

Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.

Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS.

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16157-62. doi: 10.1073/pnas.1311542110. Epub 2013 Sep 16.

34.

Bugs in the system.

Menachery VD, Baric RS.

Immunol Rev. 2013 Sep;255(1):256-74. doi: 10.1111/imr.12092. Review.

35.

Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury.

Gralinski LE, Bankhead A 3rd, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS.

MBio. 2013 Aug 6;4(4). pii: e00271-13. doi: 10.1128/mBio.00271-13.

36.

Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus.

Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG.

MBio. 2013 Apr 30;4(3):e00165-13. doi: 10.1128/mBio.00165-13.

37.

Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells.

Sims AC, Tilton SC, Menachery VD, Gralinski LE, Schäfer A, Matzke MM, Webb-Robertson BJ, Chang J, Luna ML, Long CE, Shukla AK, Bankhead AR 3rd, Burkett SE, Zornetzer G, Tseng CT, Metz TO, Pickles R, McWeeney S, Smith RD, Katze MG, Waters KM, Baric RS.

J Virol. 2013 Apr;87(7):3885-902. doi: 10.1128/JVI.02520-12. Epub 2013 Jan 30.

38.

Corneal replication is an interferon response-independent bottleneck for virulence of herpes simplex virus 1 in the absence of virion host shutoff.

Pasieka TJ, Menachery VD, Rosato PC, Leib DA.

J Virol. 2012 Jul;86(14):7692-5. doi: 10.1128/JVI.00761-12. Epub 2012 May 2.

39.

Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection.

Menachery VD, Pasieka TJ, Leib DA.

J Virol. 2010 Oct;84(19):9685-94. doi: 10.1128/JVI.00706-10. Epub 2010 Jul 21.

40.

Control of herpes simplex virus replication is mediated through an interferon regulatory factor 3-dependent pathway.

Menachery VD, Leib DA.

J Virol. 2009 Dec;83(23):12399-406. doi: 10.1128/JVI.00888-09. Epub 2009 Sep 16.

41.

Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state.

Pasieka TJ, Lu B, Crosby SD, Wylie KM, Morrison LA, Alexander DE, Menachery VD, Leib DA.

J Virol. 2008 Jun;82(11):5527-35. doi: 10.1128/JVI.02047-07. Epub 2008 Mar 26.

Supplemental Content

Loading ...
Support Center